source
- GSK to invest $800 million in new biologics manufacturing hub in PennsylvaniaGSK announced it will spend more than $800 million to expand its Upper Merion site near Philadelphia, adding biologics production capacity. The plan includes demolishing existing structures next y…
- Undecimal Bio raises $18 million to expand siRNA platform beyond liver diseasesUndecimal Bio, founded by Yaniv Erlich and Shaul Ilan, announced a new financing round that brings in $18 million. The capital will support the company’s effort to develop siRNA therapeutics for ta…